乳腺癌术后化疗病人恐惧疾病进展心理及其影响因素分析

    Analysis of fear disease progression and its influencing factors in breast cancer patients treated with postoperative chemotherapy

    • 摘要:
      目的调查乳腺癌术后化疗病人恐惧疾病进展心理情况,分析其影响因素。
      方法采用病人一般资料调查表、恐惧疾病进展简化量表、社会支持评定量表和Herth希望量表对312例乳腺癌术后病人进行调查。
      结果病人恐惧疾病进展评分为(38.54±5.26)分,其中生理健康维度为(20.23±3.03)分,社会家庭维度为(18.30±2.46)分。不同年龄、文化程度、家庭人均月收入、工作状态和有无复发或转移的乳腺癌术后化疗病人恐惧疾病进展评分差异均有统计学意义(P < 0.01)。Pearson相关分析显示,病人恐惧疾病进展评分与社会支持评分呈明显负相关关系(P < 0.01),与希望水平评分呈明显负相关关系(P < 0.01)。多元线性回归分析显示,年龄、文化程度、家庭人均月收入、有无复发或转移、社会支持和希望水平均为病人恐惧疾病进展的独立影响因素(P < 0.01)。
      结论医务人员应重视乳腺癌术后化疗病人的恐惧疾病心理水平及其影响因素特点,为病人提供有效的临床心理干预。

       

      Abstract:
      ObjectiveTo investigate the level of fear disease progression in breast cancer patients treated with postoperative chemotherapy, and analyze its influencing factors.
      MethodsThree hundred and twelve postoperative patients with breast cancer were investigated using general information questionnaire, fear of progression questionnaire-short form, social support rating scale and Herth hope index.
      ResultsThe score of fear disease progression was(38.54±5.26), and the physiological health dimension score and social and family dimension score were(20.23±3.03) and(18.30±2.46), respectively.The differences of the scores of fear disease progression in different ages, education levels, per capita monthly income, working status and relapse or metastasis breast cancer patients treated with postoperative chemotherapy were statistically significant(P < 0.01).The results of the Pearson correlation analysis showed that the score of fear disease progression was significantly negatively correlated with the scores of social support and hope level(P < 0.01).The results of multiple linear regression analysis showed that the age, education level, family per capita monthly income, recurrence or metastasis, social support and hope level were the independent influencing factors of fear disease progression of patients(P < 0.01).
      ConclusionsMedical staff should pay more attention to the level of fear disease progression and its influencing factors in breast cancer patients treated with postoperative chemotherapy, and provide effective clinical psychological intervention.

       

    /

    返回文章
    返回